Loading
A Beijing cancer genomics company whose researchers co-developed the INSPECTOR methylation blood test for eight cancers.
Geneplus-Beijing, whose employees co-authored the INSPECTOR study with Sun Yat-sen University Cancer Center (Cancer Communications 2025), develops an enzyme-assisted methylation sequencing test for eight cancers through its early cancer screening research department.
A methylation blood test for eight cancers from Geneplus-Beijing and Sun Yat-sen University Cancer Center, which found about eight in ten cancers in people already diagnosed; it has not been tested in a screening population.
Shares Cell-free DNA methylation tests, Multi-cancer early detection (MCED), Liquid biopsy (ctDNA).
Shares Cell-free DNA methylation tests, Multi-cancer early detection (MCED), Liquid biopsy (ctDNA).
Shares Cell-free DNA methylation tests, Multi-cancer early detection (MCED), Liquid biopsy (ctDNA).
Shares Cell-free DNA methylation tests, Multi-cancer early detection (MCED), Liquid biopsy (ctDNA).
Shares Cell-free DNA methylation tests, Multi-cancer early detection (MCED), Liquid biopsy (ctDNA).
Shares Cell-free DNA methylation tests, Multi-cancer early detection (MCED), Liquid biopsy (ctDNA).
Shares Multi-cancer early detection (MCED), Liquid biopsy (ctDNA).
Shares Multi-cancer early detection (MCED), Liquid biopsy (ctDNA).
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/